| UHC Commercial Medical & Drug | Ryplazim® (Plasminogen, Human-Tvmh) - Commercial Medical Benefit Drug Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Screening Colonoscopy Procedures - Site of Service - Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Simponi Aria® (Golimumab) Injection for Intravenous Infusion - Commercial Medical Benefit Drug Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Surgery of the Hip - Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Surgery of the Knee - Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Tocilizumab (Actemra®, Tofidence®, & Tyenne®) Injection for Intravenous Infusion - Commercial Medical Benefit Drug Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Treatment of Temporomandibular Joint Disorders - Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Virtual Upper Gastrointestinal Endoscopy - Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC UMR Medical and Drug | Airway Clearance Devices - Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC UMR Medical and Drug | Computerized Dynamic Posturography - Commercial and Individual Exchange Medical Policy | 2026-03-01 |